Clinical Topics & News

Teva Announces FDA Approval of Ajovy (fremanezumab-vfrm)

Publish date: September 25, 2018

Teva Pharmaceutical Industries Ltd. announced that the FDA approved Ajovy (fremanezumab-vfrm) injection for the preventive treatment of migraine...

Publish date: July 30, 2018

Publish date: June 14, 2017

During the past 20 years, mindfulness-based training has become an increasingly popular treatment for many conditions, including migraine. In the...